未登录

S

Steven G. Morgan

University of British Columbia

H指数:35

被引数:3,990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The cost of potentially inappropriate medications for older adults in Canada: A comparative cross-sectional study

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2024-09-050

OAAI

Pharmacare Act does not prescribe universal, public pharmacare

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2024-08-112

OAAI

When will Canada have national pharmacare?

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2024-04-220

PRE

Factors influencing the effects of policies and interventions to promote the appropriate use of medicines in high-income countries: A rapid realist review

IF3.4

2024-04-012

OAAI

Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial

JAMA HEALTH FORUM

IF11.3

2023-05-262

OAAI

Failure to follow medication changes made at hospital discharge is associated with adverse events in 30 days

HEALTH SERVICES RESEARCH

IF3.2

2020-05-2019

OAAI

Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

IF4.5

2020-03-3145

OAAI

Variation in the prescription drugs covered by health systems across high-income countries: A review of and recommendations for the academic literature

IF3.4

2020-03-011

PREAI

Pricing of pharmaceuticals is becoming a major challenge for health systems

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2020-01-1386

OAAI

New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2020-01-1328

OAAI

Should national pharmacare apply a value-based insurance design?

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2019-07-213

OAAI

How to pay for national pharmacare

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2018-11-254

OAAI

An analysis of expenditures on primary care prescription drugs in the United States versus ten comparable countries

IF3.4

2018-09-019

PREAI

New generic pricing scheme maintains high prices and risks of shortages

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2018-04-096

OAAI

Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study

JOURNAL OF SEXUAL MEDICINE

IF3.3

2017-12-014

PREAI

Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application

SOCIAL SCIENCE & MEDICINE

IF5

2017-12-0130

PREAI

The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis

IMPLEMENTATION SCIENCE

IF13.4

2017-11-255

OAAI

Evaluating the effects of Quebec's private-public drug insurance system

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2017-10-0915

OAAI

Drivers of expenditure on primary care prescription drugs in 10 high-income countries with universal health coverage

CANADIAN MEDICAL ASSOCIATION JOURNAL

IF11.3

2017-06-1137

OAAI

A rapidly changing global medicines environment: How adaptable are funding decision-making systems?

IF3.4

2017-06-018

PREAI